Clin2
NCT07624669Possibly a fitNot yet recruiting

Tetanus vaccine patch study in healthy adults

Vaccine DeliveryTetanus

Part of Infections clinical trials.

This study tests a new microneedle patch that delivers a tetanus booster vaccine through tiny needles in the skin, without a traditional shot. The patch is applied to the forearm, and the study checks its safety and how the body responds.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
30 people
Ages
16 years and older
Study type
Interventional

Who can take part

  • You are a healthy adult (aged 16 or older).
  • You have a patch of hairless, unblemished skin on your inner forearm (at least about 1 inch square) — no tattoos, burns, scars, or skin conditions there.
  • If you are a woman who could become pregnant, you agree to use reliable birth control during the study.
  • You have not had a tetanus booster in the last 12 months.
  • You are not allergic to tetanus vaccine or materials in the patch (like plastic or adhesive).
  • You have not used immune-suppressing drugs (like high-dose steroids) in the last 30 days and do not have an active infection.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07149454Enrolling by invitation· Phase 1
Testing a new antibody to prevent tetanus

This trial tests a new medicine made from antibodies that target tetanus toxin. It may help protect people from tetanus without needing a vaccine.

Lanzhou, Gansu
NCT07633119Not yet recruiting· Phase 3
Study of an injection to prevent tetanus after high-risk exposure

This study tests an injection that may help prevent tetanus in people who have had a high-risk exposure, like a deep or dirty wound. It aims to see if the injection is safe and effective for protecting against tetanus.

Fuyang, Anhui
NCT07492303Not yet recruiting· Phase 1
Vaccine for whooping cough, diphtheria, and tetanus in teens and adults

This trial tests a new combined vaccine that protects against whooping cough, diphtheria, and tetanus for people aged 10 and older. It aims to see if the vaccine is safe and how well it works to boost immunity in teens and adults.

NCT07446166Not yet recruiting
Testing tetanus antibodies in saliva

This study checks if a simple saliva test can detect tetanus protection, which could replace blood tests. It includes healthy children, young adults, pregnant women, and adults with certain health conditions.

Kigali
NCT07347938Recruiting
Tetanus prevention after injury: study of siltartoxatug

This study compares a new tetanus shot (siltartoxatug) with standard tetanus treatments to see if it works as well. It is for people aged 18 and older who need tetanus protection after an injury.

Hangzhou, Zhejiang
NCT07807033Not yet recruiting
Long-term immune response check after tetanus vaccine

This study checks how long your body's protection from the tetanus vaccine lasts. It follows up with people who already got the vaccine in an earlier study to see if their immunity is still strong years later.

Bijie, Guizhou

Hear when a new Tetanus trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.